1 Min Read
Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance The post MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated? appeared first on MedCity News.
Work & Theory on February 22, 2026
Uncategorized